newsletter-header-logo2
Eisner Safety Consultants Newsletter Issue 2 — October 5, 2009
IN THIS ISSUE

Newsletter Summary

This issue we are going to focus on the MDD Amendment 2007/47/EC including our toolkit to make you transition much easier and an interpretative EC guidance on the implementation of 2007/47/EC. These are both great resources to use to get you thru this transition. Also, we will focus on EU vigilance reporting per MEDDEV 2.12-1, revision 5 and record retention requirements per ISO 13485, ISO 9000, MDD, AIMDD, & IVD. These last two topics are good reminders to check your quality system procedures, forms, and records to ensure you are meeting the proper requirements prior to your next audit by a registrar or EU Notified Body. We hope you enjoy this edition of the newsletter and we would enjoy hearing back from you on any suggested topics and your feedback.
NEWS
  • Newsletter Summary
  • MDD Amendment Toolkit Now Available
  • MDD Amendment Implementation Guide
  • EU Vigilance Reporting
  • Record Retention Times

Now Available Toolkit to help meet MDD Amendment 2007/47/EC - Only $249.00

The changes to the current EC Medical Device Directive (MDD) 93/42/EEC become mandatory on March 21, 2010. Are you ready for all the changes? All manufacturers of CE marked medical devices must be in compliance by that date. There is no transition date for the amendment 2007/47/EC. Eisner Safety Consultants in conjunction with Roberts Consulting & Engineering is offering a package for device manufacturers to assist them in complying with the changes. Click here to order the package.

The CD package contains the following useful resources to make your job easier in meeting the new changes in a timely and efficient manner. The documents are Word 2003 formatted other than the 2 presentations are in PowerPoint 2003 format:

  1. Suggested project plan for transition to the amended MDD.
  2. Gap Analysis Checklist as a self-assessment tool. It identifies the changes and provides suggestions of how to address any gaps.
  3. Two PowerPoint Training Presentations: A detailed review of the changes - can be used to train staff members that are directly involved in implementing the change. An overview presentation - suitable for training all levels of employees.
  4. Updated essential requirements (ER’s) checklist. There are many changes & some reorganization of Annex I ER’s. Use this to revise your technical files or dossiers.
  5. Declaration of conformity (DoC) template. There are some changes to the expectation of the contents in the DoC. It is expected new DoC’s will be required for all products to state compliance with the directive as revised by 2007/47/EC. These will need to be in place by March 21, 2010.
  6. Clinical data SOP & report template. The revised MDD requires all classes of device have clinical data. The SOP is based on MEDDEV 2.7 and includes templates for a literature search protocol and a clinical data literature report.The revised MDD also requires that clinical data be updated over time. The clinical data SOP addresses this by including requirements for Post Market Clinical Follow Up per MEDDEV 2.12-2.
  7. Usability SOP & report template. A major change to the ER’s is that the user of the device must be taken into account. A usability analysis will need to be performed. The SOP provides instructions for this and a template for the analysis process, which needs to start in the concept stage.

This exciting new package is now available for sale on the Eisner Safety Consultants website for $249.00. You can order with a credit card or a Paypal account. Click here to order the package. The product will be sent to you in the mail.

Interpretative EC Guidance on 2007/47/EC Implementation

Time is starting to run out. As mentioned above there will not be a transition period and any new medical device must meet the amended requirements of directive 2007/47/EC by March 21, 2010. To help you out the EC published an interpretation document addressing some implementation questions. This document is available for download from our website.

The implementation interpretative document addresses these issues: